Vtv Therapeutics Inc (VTVT)

04:50 AM

What analysts say about vTv Therapeutics Inc. stockBreakout profit opportunities - PrintWeekIndia

04:50 AM

Jul 24, 2025

What risks could impact vTv Therapeutics Inc. stock performanceSuperior profit margins - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

What makes vTv Therapeutics Inc. stock price move sharplyRisk Limited High Gain Trades - Newser

Jul 24, 2025

Jul 23, 2025

What drives vTv Therapeutics Inc. stock priceHigh-yield portfolio picks - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Is vTv Therapeutics Inc. a good long term investmentUnprecedented profit potential - Autocar Professional

Jul 23, 2025

Jul 23, 2025

vTv Therapeutics Inc. Stock Analysis and ForecastConsistent wealth multiplication - jammulinksnews.com

Jul 23, 2025

Jul 20, 2025

(VTVT) Technical Data - news.stocktradersdaily.com

Jul 20, 2025

Jul 18, 2025

vTv Therapeutics’ Phase 3 Diabetes Trial: A Potential Game-Changer? - TipRanks

Jul 18, 2025

Jul 18, 2025

What drives Deluxe Corporation stock priceMarket-beating performance - Jammu Links News

Jul 18, 2025

Jul 18, 2025

MAXN Stock Analysis and ForecastUnmatched market performance - Jammu Links News

Jul 18, 2025

Jul 18, 2025

Is Relay Therapeutics Inc. stock overhyped or has real potentialCapital Preservation Investment Ideas - Newser

Jul 18, 2025

Jul 16, 2025

TAOCAT(taocat by virtuals masa 1) Technical AnalysisDefensive Stock Picks with Upside - Newser

Jul 16, 2025

Jul 15, 2025

Leverage AI to analyze customer sentiment and adjust your marketing strategiesFree Deep Market Trend Analysis - Newser

Jul 15, 2025

Jul 15, 2025

Why vTv Therapeutics Inc. stock attracts strong analyst attentionFree Predictions - Newser

Jul 15, 2025

Jul 15, 2025

How vTv Therapeutics Inc. stock performs during market volatilityGroup Only Stock Signals - Newser

Jul 15, 2025

Jul 15, 2025

How MicroAlgo Inc. stock performs during market volatilityFree Access to Community with 300% Return - Newser

Jul 15, 2025

Jul 15, 2025

Why Sify Technologies Limited Equity Right stock attracts strong analyst attentionFree Real-Time Stock Data - Newser

Jul 15, 2025

Jul 10, 2025

Diabetes Clinical Trials, Companies, Therapeutic Assessment, - openPR.com

Jul 10, 2025

Jul 09, 2025

Trading (VTVT) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 09, 2025

Jun 30, 2025

VTv Therapeutics Inc.(NasdaqCM: VTVT) dropped from Russell Microcap Value Index - MarketScreener

Jun 30, 2025

Jun 30, 2025

VTv Therapeutics Inc.(NasdaqCM: VTVT) dropped from Russell 3000E Value Index - MarketScreener

Jun 30, 2025

Jun 29, 2025

(VTVT) Trading Report - news.stocktradersdaily.com

Jun 29, 2025

Jun 12, 2025

vTv Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 12, 2025

Jun 12, 2025

Transcript : VTv Therapeutics Inc.Special Call - MarketScreener

Jun 12, 2025

Jun 11, 2025

vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series - GlobeNewswire

Jun 11, 2025

Jun 11, 2025

vTv Therapeutics Showcases First-in-Class Type 1 Diabetes Treatment at HC Wainwright | VTVT Stock News - Stock Titan

Jun 11, 2025

Jun 06, 2025

(VTVT) Trading Signals - news.stocktradersdaily.com

Jun 06, 2025

May 21, 2025

vTv resumes Phase III oral T1D drug study - The Pharma Letter

May 21, 2025

May 19, 2025

vTv Therapeutics appoints new CFO amid Phase 3 trial By Investing.com - Investing.com South Africa

May 19, 2025

May 19, 2025

vTv Therapeutics Appoints New CFO Amidst Phase 3 Trial - TipRanks

May 19, 2025

May 19, 2025

vTv Therapeutics Appoints Michael Tung, M.D., MBA, As Chief Financial Officer - citybiz

May 19, 2025

May 19, 2025

VTv Therapeutics Names Michael Tung as Finance Chief - marketscreener.com

May 19, 2025